Skip to main content
. 2017 Apr 19;8(26):42926–42938. doi: 10.18632/oncotarget.17216

Figure 3. Treatment of MSCs with NZ or ZA decreased the migration of prostate cancer cells induced by MSCs-CM.

Figure 3

Migration of PC3 and DU145 cells through a fibronectin-coated Boyden chamber in response to serum free medium (control=100%), CM from MSCs untreated or treated with (A) NZ or (B) ZA. Histograms represent the percentage of transmigrated cells after 20 h relative to control (cells migrated towards serum free medium). Values represent the mean ± SD of N=3 independent experiments.